基于CiteSpace肿瘤相关肌肉减少症研究的知识图谱分析

doi:10.16689/j.cnki.cn11-9349/r.2020.01.016

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (3741 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To understand and analyze the research status and hot spots of domestic and overseas cancer-associated sarcopenia patients, so as to provide reference for the research in this field in China. Methods Literatures in the field of cancer-associated sarcopenia collected from CNKI, Wanfang, VIP and Web of Science （WOS） core databases from 1999 to 2018 were retrieved and analyzed visually by CiteSpace V software with bibliometrics. Results The total number of papers was on the rise, Asian countries were relatively in the lead, but highly cited literature was mainly concentrated in Europe and the United States. The research hotspots in the field of cancer-associated sarcopenia in China were related factors and prognosis of sarcopenia in patients undergoing gastrointestinal cancer surgery. The research hotspot of WOS in this field has extended to the study of prognosis of patients receiving chemotherapy and targeted drug therapy, urinary system tumors, pancreatic cancer, cholangiocarcinoma, focusing on the in-depth study of the mechanism and influencing factors, the intervention study of exercise and nutrition in this field and so on. Conclusions The study of cancer-associated sarcopenia in China is still in its infancy. Nurses should pay more attention to patients and strengthen the evaluation and screening of muscle strength, body function and nutritional status of tumour patients. On the basis of drawing lessons from foreign research methods and combining with the actual situation of our country, we should broaden the scope of research and carry out appropriate research.

Key words： Cancer Sarcopenia Research hotspots Bibliometrics

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	1Li Li
	1Lu Huanzhen
	2Ding Liping
	2Yu Jiaxiang
	2Yang Heng
	2Zhang Meining

Cite this article:

1Li Li,1Lu Huanzhen,2Ding Liping, et al. Visualization analysis of CiteSpace V on cancer-associated sarcopenia[J]. Electron J Metab Nutr Cancer, 2020, 7(1): 86-92.

URL:

http://182.92.200.144/EN/10.16689/j.cnki.cn11-9349/r.2020.01.016 OR http://182.92.200.144/EN/Y2020/V7/I1/86

1.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia：European consensus on definition and diagnosis：report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010；39(4)：412-423.
2.Naito T, Okayama T, Aoyama T, et al. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer. BMC Cancer. 2017；17(1)：571.
3.姚克青, 丛明华, 代忠, 等. 骨骼肌减少与肺癌毒性反应及化疗疗效相关性研究. 肿瘤代谢与营养电子杂志. 2018；5(1)：59-62.
4.张付峰, 卢晓琴. 肌肉减少症与肿瘤化疗. 肿瘤代谢与营养电子杂志. 2019；6(1)：110-115.
5.Nipp RD, Fuchs G, El-Jawahri A, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist. 2018；23(1)：97-104.
6.Otten L, Stobus N, Franz K, et al. Impact of sarcopenia on 1-year mortality in older patients with cancer. Age Ageing. 2019；48(3)：413-418.
7.Liang C, Luo A, Zhong Z. Knowledge mapping of medication literacy study：a visualized analysis using CiteSpace. SAGE Open Med. 2018；6：2050312118800199.
8.陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能. 科学学研究. 2015；33(2)：242-253.
9.Xiao F, Li C, Sun J, et al. Knowledge domain and emerging trends in organic photovoltaic technology：a scientometric review based on CiteSpace analysis. Front Chem. 2017；5：67.
10.侯剑华, 胡志刚. CiteSpace软件应用研究的回顾与展望. 现代情报. 2013；33(4)：99-103.
11.王璐, 陈永春, 谢晓冬. 恶性肿瘤患者肌肉减少症的诊断与营养干预. 中华临床营养杂志. 2013；21(1)：23-29.
12.Samuelsson J, Zackrisson H, Tokics L, et al. Acute quadriplegic myopathy following autologous peripheral blood stem cell transplantation for breast cancer. Bone Marrow Transplant. 1999；23(8)：835-837.
13.Huang DD, Wang SL, Zhuang CL, et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis. 2015；17(11)：256-264.
14.Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia：an international consensus. Lancet Oncol. 2011；12(5)：489-495.
15.Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity：skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013；31(12)：1539-1547.
16.Lieffers JR, Bathe OF, Fassbender K, et al. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012；107(6)：931-936.
17.Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts：a population-based study. Lancet Oncol. 2008；9(7)：629-635.
18.安兴茹. 我国词频分析法的方法论研究(I)——统计分析要素的界定、分类及问题. 情报杂志. 2016；35(2)：75-80,43.
19.Xiao J, Caan BJ, Cespedes Feliciano EM, et al. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer. Am J Clin Nutr. 2019；109(3)：615-625.
20.余静, 周福祥. 肌肉减少症在胃肠道肿瘤中的临床意义. 肿瘤代谢与营养电子杂志. 2017；4(4)：483-488.
21.Alkan 瘙塁B, Arta M, Rakcolu N. The relationship between nutritional status and handgrip strength in adult cancer patients：a cross-sectional study. Support Care Cancer. 2018；26(7)：2441-2451.
22.Fukushima H, Fujii Y, Koga F. Metabolic and molecular basis of sarcopenia：implications in the management of urothelial carcinoma. Int J Mol Sci. 2019；20(3)：760.
23.Matsuo Y, Mitsuyoshi T, Shintani T, et al. Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer. J Geriatr Oncol. 2018；9(6)：589-593.
24.戚倩, 吴蓓雯, 费晓燕. 肿瘤相关性肌肉减少症影响因素的研究进展. 中国全科医学. 2018；21(15)：1769-1774.
25.Go SI, Park MJ, Song HN, et al. Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support Care Cancer. 2016；24(5)：2075-2084.
26.Ishihara H, Takagi T, Kondo T, et al. Effect of changes in skeletal muscle mass on oncological outcomes during first-line sunitinib therapy for metastatic renal cell carcinoma. Target Oncol. 2018；13(6)：745-755.
27.李怡, 周福祥. 少肌性肥胖对肿瘤患者临床结局的影响. 肿瘤代谢与营养电子杂志. 2017；4(4)：381-389.
28.Adams SC, Segal RJ, McKenzie DC, et al. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy：a multicenter randomized controlled trial. Breast Cancer Res Treat. 2016；158(3)：497-507.
29.Peddle-McIntyre CJ, Bell G, Fenton D, et al. Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors. Lung Cancer. 2012；75(1)：126-132.
30.Dawson JK, Dorff TB, Todd Schroeder E, et al. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer：a pilot randomized controlled trial. BMC Cancer. 2018；18(1)：368.